The maker of Tylenol and Listerine said its organic sales rose 1.5% from a year earlier, slowing from 1.9% growth the prior quarter. But that was better than analyst expectations. The stock rose about 14%.
The maker of Tylenol and Listerine said its organic sales rose 1.5% from a year earlier, slowing from 1.9% growth the prior quarter. But that was better than analyst expectations. The stock rose about 14%.